Manufacturing, labeling, and release by a Qualified Person (confirming compliance with GMP requirements and Quality Assurance/QP release), storage, transport with delivery on the day of the patient's visit, disposal, and comprehensive preparation of documentation (IMPD/IB) for the Investigational Medicinal Product containing the active substance psilocybin and comparators (SSRI) (...)

Warszawski Uniwersytet Medyczny